Viatris Inc. (VTRS) Provides Updates on Four Recent Regulatory Milestones

Viatris Inc. (NASDAQ:VTRS) is one of the top cheap stocks under $20 to buy now. On December 18, Viatris Inc. (NASDAQ:VTRS) announced four recent regulatory milestones spread across all stages of the company’s global pipeline. It stated that the FDA approved the company’s octreotide acetate for injectable suspension, which is a generic version of Sandostatin® LAR Depot and indicated for treatment in patients who have responded to and tolerated Sandostatin Injection subcutaneous injection for acromegaly, pro ...